7+3+VP-16 as Remission Induction / Consolidation and Two Types of Maintenance in Adult AML: 8 Years Results of Russian Multicenter Trial

Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Н. В. Медведева(National Medical Research Center for Hematology), Н. А. Обидина(National Medical Research Center for Hematology), E. V. Yarikova(National Medical Research Center for Hematology), Т. И. Поспелова, Alexander Pristupa, С. М. Куликов(Ministry of Health of the Russian Federation), М. А. Волкова(National Medical Research Center for Hematology), Л. Б. Филатов(National Medical Research Center for Hematology), Valery Lapin, Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), L. N. Jeltukhina(National Medical Research Center for Hematology), Viktor Rossiev(Samara Regional Clinical Oncology Center), Е Р Маслова(National Medical Research Center for Hematology), Е Н Устинова, Евгений Александрович Белоусов(National Medical Research Center for Hematology), В. А. Тумаков(National Medical Research Center for Hematology), Н Н Климко(Oulu University Hospital), G. B. Rehtman(National Medical Research Center for Hematology), В Г Исаев, Valeriia Cherepanova(National Medical Research Center for Hematology), Е О Грибанова, Т. С. Константинова(Regional Children's Clinical Hospital No. 1), E. N. Parovitchnikova(National Medical Research Center for Hematology), L. Yu. Tihonova(National Medical Research Center for Hematology), L. S. Lubimova(National Medical Research Center for Hematology), T S Kaporskaya(Irkutsk Regional Clinical Hospital)
Hämatologie und Bluttransfusion
January 1, 2003
Cited by 0


Related Papers